These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15260903)

  • 21. Atypical antipsychotics and pituitary neoplasms in the WHO database.
    Doraiswamy PM; Schott G; Star K; Edwards R; Mueller-Oerlinghausen B
    Psychopharmacol Bull; 2007; 40(1):74-6. PubMed ID: 17285098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
    Feifel D; Melendez G; Priebe K; Shilling PD
    Behav Brain Res; 2007 Aug; 181(2):278-86. PubMed ID: 17559953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Chen ZH; Wang GH; Wang XP; Chen RY; Wang HL; Yang MH; Huo YX; Mei HB
    Hum Psychopharmacol; 2008 Aug; 23(6):465-70. PubMed ID: 18536066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment.
    Amado I; Bourdel MC; Daban C; Poirier MF; Loo H; Bouhours P; Krebs MO
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1107-12. PubMed ID: 19527763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
    Csomor PA; Preller KH; Geyer MA; Studerus E; Huber T; Vollenweider FX
    Neuropsychopharmacology; 2014 Sep; 39(10):2485-96. PubMed ID: 24801767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
    Koychev I; McMullen K; Lees J; Dadhiwala R; Grayson L; Perry C; Schmechtig A; Walters J; Craig KJ; Dawson GR; Dourish CT; Ettinger U; Wilkinson L; Williams S; Deakin JF; Barkus E
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):469-81. PubMed ID: 22137565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats.
    Conti LH
    Eur J Pharmacol; 2005 Jan; 507(1-3):125-34. PubMed ID: 15659302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
    Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chakragati mouse shows deficits in prepulse inhibition of acoustic startle and latent inhibition.
    Verma V; Tan CH; Ong WY; Grigoryan GA; Jones CA; Stolzberg D; Salvi R; Gross KW; Ratty AK; Dawe GS
    Neurosci Res; 2008 Mar; 60(3):281-8. PubMed ID: 18164085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males.
    Bitsios P; Giakoumaki SG; Theou K; Frangou S
    Neuropsychologia; 2006; 44(12):2494-9. PubMed ID: 16698050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S; Pourcher E; Cohen H
    J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prepulse inhibition and P50 suppression: commonalities and dissociations.
    Oranje B; Geyer MA; Bocker KB; Leon Kenemans J; Verbaten MN
    Psychiatry Res; 2006 Aug; 143(2-3):147-58. PubMed ID: 16879870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia.
    Ezewuzie N; Taylor D
    J Psychopharmacol; 2006 Jan; 20(1):86-90. PubMed ID: 16174679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients.
    Sweeney JA; Bauer KS; Keshavan MS; Haas GL; Schooler NR; Kroboth PD
    Neuropsychopharmacology; 1997 Mar; 16(3):217-28. PubMed ID: 9138438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.